Kyowa Kirin Co., Ltd.: all 233 studies
Page 3 of 3. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.
- An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal GranisetronCompletedNCT00868764Phase 1
- A Phase 2 Study of OPC-262 in Patients With Type 2 DiabetesCompletedNCT00857558Phase 2
- A Study of KRN23 in X-linked HypophosphatemiaCompletedNCT00830674Phase 1
- Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) (Protocol Number: 2449-US-002)TerminatedNCT00779480Phase 1
- Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple MyelomaTerminatedNCT00775502Phase 1
- A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer PatientsCompletedNCT00684632Phase 3
- A Phase III Clinical Study of KW-2246CompletedNCT00683995Phase 3
- Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa TherapyCompletedNCT00610103Phase 2
- A Phase 1 Study of ARQ 197 in Patients With Solid TumorsCompletedNCT00609921Phase 1
- Efficacy and Safety Study of Nasalfent for Treatment of Breakthrough Cancer Pain in Patients Taking Regular OpioidsCompletedNCT00589823Phase 3
- Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal CancerCompletedNCT00575562Phase 1
- Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular OpioidsCompletedNCT00459277Phase 3
- Long Term Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer PainCompletedNCT00458510Phase 3
- A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's LymphomaCompletedNCT00457782Phase 1
- 12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/CarbodopaCompletedNCT00456794Phase 2
- 12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/CarbidopaCompletedNCT00456586Phase 2
- A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking LevodopaCompletedNCT00455507Phase 2
- Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic PatientsCompletedNCT00364468Phase 2
- A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid TumorCompletedNCT00359840Phase 2
- Clinical Study of KW-2246 in Patients With Cancer PainCompletedNCT00355628Phase 2
- A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer PatientsCompletedNCT00344409Phase 3
- Safety Study of AMG 531 in Japanese Subjects With ITPCompletedNCT00305435Phase 2
- To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)CompletedNCT00273468Phase 3
- Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.CompletedNCT00262678Phase 3
- A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's DiseaseCompletedNCT00250393Phase 2
- Study of Istradefylline (KW-6002) for the Treatment of Restless Legs SyndromeCompletedNCT00199446Phase 2
- A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) PatientsCompletedNCT00199433Phase 2
- A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on LevodopaCompletedNCT00199420Phase 3
- A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking LevodopaCompletedNCT00199407Phase 3
- A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's DiseaseCompletedNCT00199394Phase 3
- An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018CompletedNCT00199368Phase 3
- A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking LevodopaCompletedNCT00199355Phase 2
- A Study of a Monoclonal Antibody, KW-2871, in Patients With Advanced MelanomaTerminatedNCT00199342Phase 1/2